RIL
CTKB icon

Rothschild Investment LLC’s Cytek Biosciences CTKB Stock Holding History

Rothschild Investment LLC’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72K Buy
394
+118
+43% +$557 ﹤0.01% 2623
2025
Q4 		$1.39K Buy
276
+11
+4% +$51 ﹤0.01% 2545
2025
Q3 		$920 Buy
265
+115
+77% +$432 ﹤0.01% 2621
2025
Q2 		$510 Sell
150
-75
-33% -$250 ﹤0.01% 2740
2025
Q1 		$902 Buy
225
+80
+55% +$415 ﹤0.01% 2400
2024
Q4 		$941 Buy
145
+75
+107% +$447 ﹤0.01% 2252
2024
Q3 		$388 Buy
70
+30
+75% +$170 ﹤0.01% 2543
2024
Q2 		$223 Buy
40
+20
+100% +$120 ﹤0.01% 2454
2024
Q1 		$134 Buy
+20
New +$158 ﹤0.01% 1994

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rothschild Investment LLC's CTKB Position: Q1 2026 in Review

Rothschild Investment LLC increased its Cytek Biosciences (CTKB) stake by 43% in Q1 2026, buying an estimated $557 and bringing the position to 394 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #2623.

Rothschild Investment LLC first reported a position in CTKB in Q1 2024 and has held it in 9 quarters since. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • Rothschild Investment LLC held 394 shares of Cytek Biosciences worth $1.72K as of Q1 2026.
  • Rothschild Investment LLC bought 118 Cytek Biosciences shares in Q1 2026, an estimated $557.
  • Cytek Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2623 holding.
  • Rothschild Investment LLC first reported a position in Cytek Biosciences in Q1 2024 and has held it in 9 quarters since.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.